In a notable development, lawmakers in Colorado and Virginia are standing firm against proposed restrictions on prescription drug affordability boards.
These boards play a crucial role in overseeing and potentially regulating drug prices, and the resistance from state legislators suggests a commitment to maintaining their authority.
The ongoing discussions reflect broader concerns about drug affordability and access, as states grapple with the complexities of healthcare costs.